Jason B. Daly insider trades
Open-market stock purchases and sales by Jason B. Daly, EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 3, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold | $3.7M |
| Aug 11, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold | $117K |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $207K |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $135K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $221K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $140K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $1.8M |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- AMRX Amneal Pharmaceuticals, Inc: 7 sales, last Aug 12, 2026